Low impact
UniQure plans to seek FDA approval for a Huntington's disease gene therapy after a public clash with the agency over clinical trial data.
Finnhub06/17, 11:12 PM
Related assets
Coming up for QURE
Explore next
Latest QURE news
Finnhub06/17, 07:37 PM
bloomberg-industries06/17, 06:27 PM